Jenny Hill is a public health epidemiologist with an MSc in Medical Parasitology from the London School of Hygiene & Tropical Medicine and a PhD on the delivery, access and use of interventions to control malaria in pregnancy in sub-Saharan Africa from the University of Amsterdam. Between 1989 and 1995, she worked for UNICEF to develop community based malaria control programmes as part of broader child survival programmes in Kenya, Uganda, Zambia, northern Namibia and Botswana. Since 1996, she has worked at LSTM, previously as Deputy Director of the DFID-funded Malaria Consortium. In 2004 she moved to the Malaria Epidemiology unit, led by Professor Feiko ter Kuile, to establish the Malaria in Pregnancy Consortium. Since its launch in 2007, she has been the Project Manager and a researcher, coordinating the Public Health Impact research theme (see Research activities).
Research interests focus on strategies for optimizing the delivery of malaria control interventions which target vulnerable groups, in particular pregnant women and young children. Current projects include: Implementation research to explore the factors which affect the access, delivery and use of interventions to control malaria in pregnancy in the context of other reproductive health services within routine health systems. Acceptability, feasibility and cost effectiveness of new strategies to prevent malaria in pregnancy, including intermittent screening and treatment (ISTp) and alternative drugs to sulphadoxine-pyrimethamine for intermittent preventive treatment (IPTp), in Kenya, Mali, Malawi, Tanzania and Indonesia.
PhD student: Oluwakemi (Kemi) Tesfazghi
“Accelerating access to new vector control tools: the diffusion of evidence through health policy networks”
Member of the Roll Back Malaria Working Group on Malaria in Pregnancy (2006-present)
Member of the Roll Back Malaria Working Group on Insecticide treated nets (1999-present)
2016 to 2017| Africa
European Developing Countries Clinical Trials Partnership (EDCTP). Principal Investigator: Maximising the public health impact of interventions to control malaria in pregnancy through the translation of EDCTP-funded evidence-based global policies to country level policies and plans
Gates Foundation through a grant to WWARN, Oxford. Grant holder: Develop WWARN module on malaria in pregnancy
European Developing Countries Clinical Trials Partnership (EDCTP). Co-Investigator: IPTp with dihydroartemisinin-piperaquine and azithromycin for malaria, sexually transmitted and reproductive tract infections in pregnancy in high sulphadoxine-pyrimethamine resistance areas in Kenya, Malawi, and Tanzania. Principle Investigator: Acceptability, feasibility and cost effectiveness studies
2011 to 2017 | Indonesia
DFID/MRC/Wellcome Trust. Co-Investigator: Intermittent screening and treatment or intermittent preventive therapy for control of malaria in pregnancy in Indonesia. Principle Investigator: Acceptability, feasibility and cost effectiveness studies
2007 to 2017| Global
Bill and Melinda Gates Foundation. Co-Investigator and Project manager: Malaria in Pregnancy Consortium. Principal Investigator: Public health impact studies
2008 to 2014
European Developing Countries Clinical Trials Partnership (EDCTP). Co-Investigator: Optimization of the existing dose and regimen of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria in pregnancy in the context of high coverage of insecticide treated nets and highly seasonal malaria transmission.